i2E scores a win for state in Oklahoma, leverages $23M in additional capital
We had the opportunity to showcase innovation 2 Enterprise in a web-workshop earlier this year, a Oklahoma state supported POC/seed stage accelerator/investor. They recently reported a major success in leverging $23 M for Selexys Pharma and MPM Capital to sickle cell and Crohn’s drugs. Pending a successful trial there could be a payout of nearly […]
University of California Office of the President announces new round of POC Commercialization Gap Grants
The UC Office of the President’s Proof of Concept (PoC) Commercialization Gap Grants program funds promising innovations that are nearly ripe for the market, but require one last round of testing or demonstration to prove commercial viability. Then investors and industry partners, perhaps, will come calling. A total of $2.6M was awarded to 22 researchers at six […]
U Chicago Innovation Fund supports POC study for a predictive healthcare approach
This study demonstrated the usefulness and accuracy of VG-Bio’s system and helped the company in December 2011 to win a $75,000 grant from the University of Chicago’s Innovation Fund, which is administered by UChicagoTech. The grant is funding a larger proof-of-concept study that will help VG-Bio continue raising venture capital and move its product further […]